The healthcare industry has seen exponential investment growth over the past several years, with Covid-19 creating enormous disruption and resulting opportunities for new technologies to emerge. In 2022, the healthcare industry continues to see strong investor fundraising activity despite a difficult public market and the slow decline in valuations. Company investment is down from 2021’s record activity but still at 2020’s pace.
Register to participate in a live webinar moderated by Sarah Pringle, Health Tech Reporter, Axios, featuring experts including:
• Mira Chaurushiya - Ph.D, Senior Partner, Westlake Village BioPartners
• Deena Shakir - Partner, Lux Capital
• Jon Norris - Managing Director, Healthcare at SVB
In the webinar you will learn:
• The latest healthcare trends and insights from SVB’s Healthcare Investments and Exits - covering insights for the first half of 2022
• The investor outlook: Fundraising, investments and exits
• Potential impacts to the healthcare industry – heading into a recession
• Probable challenges with the overturning of Roe v Wade and women’s health
• Biopharma, Device, Healthtech and Dx/Tools technology and trends to watch
REGISTER TODAY and get the healthcare market trends.
Questions?
Please email Courtney McClintock at cmcclint@svb.com.
Empathy Banks Here: SVB is here to help. For additional information on resources available to you and your community during the COVID-19 pandemic, please visit https://www.svb.com/covid-relief
Dr. Mira Chaurushiya is a Senior Partner at Westlake Village BioPartners. As a biologist who worked in industry research before entering the venture capital industry, she has a long and successful track record in both biological sciences and life-sciences investing.
Dr. Chaurushiya is a fellow of the Society of Kauffman Fellows. After a postdoctoral fellowship in physiological chemistry at Genentech, she joined 5AM Ventures as an associate and took on positions of increasing responsibility, culminating as a partner. During her tenure at 5AM Ventures, she invested in and served as director or observer on the boards of multiple organizations, including Precision Nanosystems (acquired by Danaher), Ideaya Biosciences (IDYA), Enliven Therapeutics, Escient Pharmaceuticals, Magnetic Insight, Novome Biotechnologies, Purigen Biosystems, NodThera and TMRW.
Dr. Chaurushiya received her Ph.D. in biological sciences from the University of California, San Diego in conjunction with the Salk Institute for Biological Studies, where she was awarded the Martin Kamen Thesis Prize in Biochemistry. She received her bachelor's degree in biology from Carleton College. She serves on the board of Biotech Connection Bay Area, a non-profit that focuses on career development for academic scientists.
Deena Shakir is a Partner at Lux Capital, where she invests in transformative technologies improving lives and livelihoods. Her investments span stages and sectors, and include women's health (Maven Clinic, Alife, Gameto, Adyn), digital health infrastructure (SteadyMD, H1, AllStripes, Everly Health), health equity (Waymark, Galileo, Miga), foodtech (Shiru), and fintech (Mos, Ramp, Neo.tax). Above all, she seeks out extraordinary, mission-driven founders.
Prior to Lux, Deena was a Partner at GV (formerly Google Ventures), led product partnerships at Google for health, search, and AI/ML, and directed social impact investments at Google.org. Deena also served as a Presidential Management Fellow at The U.S. Department of State under Secretary Clinton, where she helped launch President Obama’s first Global Entrepreneurship Summit.
Deena self-funded her undergraduate degree at Harvard (Social Studies and Near Eastern Languages & Civilizations) and MA at Georgetown through a variety of merit scholarships and side hustles, including co-founding her first company while in college. She is currently a Lecturer in Management at the Stanford Graduate School of Business, a Board Director for the National Venture Capital Association, a member of Fortune's Most Powerful Women, Kauffman Fellows, Aspen Finance Fellows, The Council on Foreign Relations, and All Raise.
Deena is a frequent speaker and commentator and has been featured in print and television on Bloomberg, CNBC and NBC, in print in the Wall Street Journal, Fortune, Forbes, Techcrunch, Marie Claire, STAT, and more, and has delivered keynote addresses at major industry conferences. She was named a "Top 30 Under 40 in Healthcare" by Business Insider, "Top Senior Women to Watch in Venture Capital" by the Wall Street Journal, and "Top 50 in Digital Health" by Rock Health.
Jonathan Norris is a managing director for business development in SVB's Healthcare practice. Norris oversees business development efforts for banking and lending opportunities as well as spearheading strategic relationships with many healthcare venture capital firms. He also helps SVB Capital through sourcing and advising on limited partnership allocations.
In addition, he speaks at major investor and industry conferences and authors widely cited analyses of healthcare venture capital trends. Norris has more than nineteen years of banking experience working with healthcare companies and venture capital firms.
Norris earned a bachelor's degree in business administration from the University of California, Riverside and a juris doctorate from Santa Clara University.
If you have any questions, please contact Courtney McClintock at cmcclint@svb.com
You can manage your email preferences, or unsubscribe from receiving promotional or marketing email communications from Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, at any time by visiting the Manage Email Preferences page.
Read about our Privacy Notice. If you have any questions or concerns about our Privacy Notice, please contact us by email: privacyoffice@svb.com. Also read about our Cookie Notice.
Banking, lending, and trust products or services are offered by Silicon Valley Bank, a division of First-Citizens Bank & Trust Company. Accounts are subject to credit approval. Restrictions and limitations may apply.
SVB Wealth LLC (“SVBW”) and SVB Asset Management (“SAM”) are non-bank subsidiaries of Silicon Valley Bank a division of First-Citizens Bank & Trust Company. SVBW and SAM are SEC-registered investment advisers; Member FINRA and SIPC.
Services offered by SAM or SVBW are not FDIC insured, not insured by any federal government agency, not bank guaranteed, and may lose value.
©2024 First-Citizens Bank & Trust Company. All rights reserved. Silicon Valley Bank, a division of First-Citizens Bank & Trust Company. 3003 Tasman Drive, Santa Clara, CA 95054. Member FDIC.
SVB’s mission is to help innovators and their investors move bold ideas forward fast. SVB Events create an environment for SVB clients, prospects, partners and employees to connect, learn from each other, pursue big ideas and make a powerful impact on people’s lives. Through our events, we help SVB to achieve its mission.
SVB does not tolerate disrespectful or harassing behavior, conversations or interactions by any event attendee, in any form, at any aspect of the program, regardless of the event location.
As an SVB event attendee, we encourage you to assist in creating a welcoming and safe networking environment. SVB reserves the right and retains sole discretion to refuse admittance to, or remove any person from, an event at any time.
Please report any violation of the Event Entertainment Code of Conduct to the following:
• Security Guard onsite
• SVB Event
• Venue Staff
If you feel that an SVB event is against our code of conduct policy or inconsistent with SVB’s culture, please contact:
SVB Events
Heidi Bianchi | 650.855.3050
SVB Financial Group Code of Conduct Policies
Evelyn De la Cruz | 312.704-9525